Form 4 for CRMD CorMedix Inc.
Accepted 2023-12-14 00:00:00 ET · period of report 2023-12-12 · accession 0000929638-23-003428 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-14 | 2023-12-12 | CRMD | Zelnick Kaufman Beth | CLO | A - Grant | $0.00 | +50.0K | 50.0K | New | $0 |
| D | 2023-12-14 | 2023-12-12 | CRMD | Zelnick Kaufman Beth | CLO | A - Grant | $0.00 | +200.0K | 200.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-12 | A | A | 50,000 | $0.00 | 50,000 | D | — | — | (F1) These Restricted Stock Units were granted on 12/12/2023. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date. |
| 2 | Derivative | Stock Option (Right to Buy Common Stock) | 2023-12-12 | A | A | 200,000 | $0.00 | 200,000 | D | $3.30 · — to 2033-12-11 | 200,000 Common Stock | (F2) These options were granted on 12/12/2023. These options vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date. |